Early Cancer Diagnosis in Primary Care - Lung Cancer & Prostate Cancer

我们将使用数字健康平台来帮助早期识别肺癌和前列腺癌患者。数字健康产品将审查医疗记录，以确定患有这些类型癌症的风险增加的患者，包括年龄，生活方式选择，家族史和症状。当在最早阶段被诊断时，几乎十分之九（88%）的肺癌患者将在疾病中存活一年或更长时间，而在最新阶段被诊断时，大约五分之一（19%）的人将存活一年或更长时间。当在最早阶段被诊断时，几乎每10名肺癌患者中有6名（57%）将在疾病中存活5年或更长时间，而当疾病在最新阶段被诊断时，几乎每100名患者中有5名（3%）。当在最早阶段被诊断出来时，所有（100%）前列腺癌患者将在疾病中存活一年或更长时间，而当疾病在最新阶段被诊断出来时，几乎每10人中有9人（88%）将存活一年或更长时间。在早期诊断时，所有（100%）前列腺癌患者都能存活五年或更长时间，相比之下，约为1/2（49%），然后将这些数据提交给临床医生，让他们决定是否需要进行进一步的调查。我们的目标是增加这些癌症的早期发现率，如果这项计划成功，我们可以利用同样的原理，在早期阶段发现其他癌症。

We will be using a digital health platform to help early identification of patients with lung and prostate cancer. The digital health product will be reviewing medical notes to identify patients who have an increased risk of these types of cancers, including age, lifestyle choices, family history and symptoms.* When diagnosed at its earliest stage, almost 9 in 10 (88%) people with lung cancer will survive their disease for one year or more, compared with around 1 in 5 (19%) people when the disease is diagnosed at the latest stage.* When diagnosed at its earliest stage, almost 6 in 10 (57%) people with lung cancer will survive their disease for five years or more, compared with almost 5 in 100 (3%) people when the disease is diagnosed at the latest stage.* When diagnosed at its earliest stage, all (100%) people with prostate cancer will survive their disease for one year or more, compared with almost 9 in 10 (88%) people when the disease is diagnosed at the latest stage.* When diagnosed at its earliest stage, all (100%) people with prostate cancer will survive their disease for five years or more, compared with around 1 in 2 (49%) people when the disease is diagnosed at the latest stage.This data will then be presented to a clinician for them to make a decision on whether further investigations are required.We aim to increase the detection of these cancers at an early stage, thereby improving the outcome and life expectancy for patients.If this project is successful, we can use the same principle in detecting other cancers at an early stage.